Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses

K. Gary Magdesian, Patricia M. Hogan, Noah D. Cohen, Gordon W. Brumbaugh, William V. Bernard

Journal of the American Veterinary Medical Association · 1998 · 50 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

OBJECTIVE: To evaluate pharmacokinetics of a high dose of gentamicin administered i.v. or i.m. to horses. DESIGN: Repeated-measures study. ANIMALS: 6 clinically normal female adult stock-type horses. PROCEDURE: All horses were given gentamicin (6.6 mg/kg [3 mg/lb] of body weight), i.v. and i.m., in a two-way cross-over design. Serum gentamicin concentrations were measured during a 24-hour period. RESULTS: Plasma concentration curves were consistent with a two-compartment model. Maximum plasma gentamicin concentrations were 71.9 +/- 15.7 micrograms/ml (0 hours after injection) and 22.0 +/- 4.9 micrograms/ml (1.31 hours after injection) for the i.v. and i.m. groups, respectively. Area under the curve (AUC) was 116.6 +/- 14.5 and 116.3 +/- 14.6 micrograms.h/ml for the i.v. and i.m. groups, respectively. Elimination half-life for the IV group was 3.0 +/- 2.8 hours. Trough concentrations were < 2 micrograms/ml for > 15 and > 12 hours for the i.v. and i.m. groups, respectively. Significant changes were not detected in clinicopathologic variables before and after administration of gentamicin. CLINICAL IMPLICATIONS: Administration of a high dose of gentamicin i.v. or i.m. resulted in peak plasma concentrations, AUC, and minimum trough plasma concentrations. Results indicate once-daily administration of gentamicin might be as efficacious and safe as multiple-dose daily administration in accordance with traditional low-dose regimens, similar to those used in other species.